ArticleFrontiers in oncology2021

RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers.

Hannah G Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.